I

InterCure Ltd
TASE:INCR

Watchlist Manager
InterCure Ltd
TASE:INCR
Watchlist
Price: 498.2 ILS -5.46% Market Closed
Market Cap: 239.6m ILS
Have any thoughts about
InterCure Ltd?
Write Note

InterCure Ltd
Net Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

InterCure Ltd
Net Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Income CAGR 3Y CAGR 5Y CAGR 10Y
I
InterCure Ltd
TASE:INCR
Net Income
-â‚Ş63.5m
CAGR 3-Years
-21%
CAGR 5-Years
-38%
CAGR 10-Years
-25%
Teva Pharmaceutical Industries Ltd
TASE:TEVA
Net Income
-$773m
CAGR 3-Years
42%
CAGR 5-Years
29%
CAGR 10-Years
N/A
Sol Gel Technologies Ltd
NASDAQ:SLGL
Net Income
-$14.9m
CAGR 3-Years
18%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Mediwound Ltd
NASDAQ:MDWD
Net Income
-$20m
CAGR 3-Years
-27%
CAGR 5-Years
N/A
CAGR 10-Years
-3%
S
Seach Medical Group Ltd
TASE:SEMG
Net Income
-â‚Ş7.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-6%
R
Rekah Pharmaceutical Industry Ltd
TASE:REKA
Net Income
â‚Ş6.8m
CAGR 3-Years
-9%
CAGR 5-Years
14%
CAGR 10-Years
0%
No Stocks Found

InterCure Ltd
Glance View

Market Cap
239.6m ILS
Industry
Pharmaceuticals

InterCure Ltd. engages in the business of medical cannabis and biomedicine. Thorugh its wholly owned subsidiary Canndoc the Company operates as licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products.

INCR Intrinsic Value
1 796.79 ILS
Undervaluation 72%
Intrinsic Value
Price
I

See Also

What is InterCure Ltd's Net Income?
Net Income
-63.5m ILS

Based on the financial report for Dec 31, 2023, InterCure Ltd's Net Income amounts to -63.5m ILS.

What is InterCure Ltd's Net Income growth rate?
Net Income CAGR 10Y
-25%

The average annual Net Income growth rates for InterCure Ltd have been -21% over the past three years , -38% over the past five years , and -25% over the past ten years .

Back to Top